The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck)
作者:Mark Sabat、John C. VanRens、Todd A. Brugel、Jennifer Maier、Matthew J. Laufersweiler、Adam Golebiowski、Biswanath De、Vijayasurian Easwaran、Lily C. Hsieh、Jeff Rosegen、Steve Berberich、Eric Suchanek、Michael J. Janusz
DOI:10.1016/j.bmcl.2006.05.072
日期:2006.8
This communication details the synthesis, biological activity, and proposed binding mode of a novel class of tri-cyclic derivatives of 1,2-dihydro-pyrimido[4,5-c]pyridazines 1 and 2. The most potent analogs disclosed showed low nanomolar activity for the inhibition of Lck kinase. (c) 2006 Elsevier Ltd. All rights reserved.